Oxytocin (Tonix Pharmaceuticals)

N/A

Report date: 2025/03/28 11:42:47

Base Information

Drug NameOxytocin (Tonix Pharmaceuticals)
Drug Alias NameIntranasal potentiated oxytocinOxytocin intranasalOxytocin solution for intranasal deliveryTNX-2900TI-001 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOxytocin receptor agonists
TargetsOxytocin receptor
Therapy Area/IndicationsPrader-Willi SyndromeCluster Headache
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesTrigemina Inc
China Registration ClassN/A

Develop Information

Active CompaniesTonix Pharmaceuticals Holding CorpTonix Pharmaceuticals Inc
Inactive CompaniesTrigemina Inc
Active IndicationsPrader-Willi Syndrome
Inactive IndicationsCluster Headache

Other Information

ATC CodeN/A
Related LinksN/A